Consonance Capital Management LP Pacira Bio Sciences, Inc. Transaction History

Consonance Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $99.8 Million - $126 Million	-2,799,916 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $31.2 Million - $40.9 Million	-852,218 Reduced 23.33%	2,799,916 $122 Million
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $3.34 Million - $5.29 Million	-101,700 Reduced 2.71%	3,652,134 $180 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $30.8 Million - $44.5 Million	1,118,918 Added 42.47%	3,753,834 $120 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $31 Million - $47.9 Million	1,032,582 Added 64.44%	2,634,916 $82.1 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $7.08 Million - $10.4 Million	222,200 Added 16.1%	1,602,334 $73.1 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $49.3 Million - $54.5 Million	1,380,134	1,380,134 $51.8 Million

266

49.4M

378K

1.43M

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $754M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.